Literature DB >> 8052655

Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.

J J Yunis1, N Mobini, E J Yunis, C A Alper, R Deulofeut, A Rodriguez, C S Foster, D Marcus-Bagley, R A Good, A R Ahmed.   

Abstract

Cicatricial pemphigoid (CP) is a chronic autoimmune blistering disease affecting multiple mucous membranes derived from stratified squamous epithelium and occasionally the skin. CP has a wide spectrum of disease manifestations. Patients with oral pemphigoid (OP) have a benign self-limited disease in which pathological changes are restricted to the oral mucosa. On the other hand, patients with ocular cicatricial pemphigoid (OCP), a chronic condition marked with relapses and remissions, have ocular involvement and also perhaps involvement of other mucous membranes. All clinical subsets are characterized by the presence of a similar anti-basement zone autoantibody. The factors that determine the development of one form of CP or the other are not known. In a previous study, we described the association between OCP and the DQB1*0301 allele (P = 0.006). In this study, we have analyzed 22 Caucasian patients with OP and their family members for major histocompatibility complex DRB generic, DQA1, and DQB1 allele associations by PCR-sequence-specific oligonucleotide probe hybridization. The results were compared to those obtained from 17 Caucasian patients with OCP and to control Caucasian alleles and haplotypes. The DQB1*0301 allele frequency was 38.6% in OP, 52.9% in OCP, and 17.8% in controls. Statistically significant associations were detected between the DQB1*0301 allele and both OP (P = 0.0047) and OCP (P < 0.0001). In addition, DRB1*04 showed a statistically significant association (P = 0.005) with OCP when compared to controls. Analysis of major histocompatibility complex class II haplotypes showed significant statistical associations between both OCP and OP and the HLA-DRB1*04, DRB4*0101, DQA1*03, DQB1*0301 haplotype (P < 0.0001 and P = 0.0012, respectively). Our results indicate that DQB1*0301 is a marker of both oral and ocular forms of CP. The analysis of the amino acid sequence of the DQB1 alleles present in both OP and OCP suggested that amino acid residues at position 57 and positions 71-77 may also be markers of CP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052655      PMCID: PMC44479          DOI: 10.1073/pnas.91.16.7747

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  HLA class II nucleotide sequences, 1992.

Authors:  S G Marsh; J G Bodmer
Journal:  Tissue Antigens       Date:  1992-11

2.  Rapid identification of HLA-DRw53-positive samples by a generic DRB-PCR amplification without further analysis.

Authors:  J J Yunis; M B Delgado; E Lee-Lewandroski; E J Yunis; D H Bing
Journal:  Tissue Antigens       Date:  1992-07

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.

Authors:  I Khalil; L d'Auriol; M Gobet; L Morin; V Lepage; I Deschamps; M S Park; L Degos; F Galibert; J Hors
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Cicatricial pemphigoid.

Authors:  A R Ahmed; S M Hombal
Journal:  Int J Dermatol       Date:  1986-03       Impact factor: 2.736

6.  Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant.

Authors:  F C Arnett; M L Olsen; K L Anderson; J D Reveille
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Characterization of a new DRB1 allele, DRB1*1309, by PCR-SSOP and sequencing.

Authors:  J J Yunis; E Kineke; E J Yunis
Journal:  Tissue Antigens       Date:  1994-01

8.  HLA-DQB1 allele typing by a new PCR-RFLP method: correlation with a PCR-SSO method.

Authors:  M Salazar; J J Yunis; M B Delgado; D Bing; E J Yunis
Journal:  Tissue Antigens       Date:  1992-09

9.  HLA-DQA1, DQB1 and DPB1 alleles on HLA-DQ2- and DQ9-carrying extended haplotypes.

Authors:  J J Yunis; M Salazar; M B Delgado; C A Alper; D H Bing; E J Yunis
Journal:  Tissue Antigens       Date:  1993-01

Review 10.  Cicatricial pemphigoid.

Authors:  A R Ahmed; B S Kurgis; R S Rogers
Journal:  J Am Acad Dermatol       Date:  1991-06       Impact factor: 11.527

View more
  11 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  Treatment and relapse of autoimmune pancreatitis.

Authors:  Sung-Hoon Moon; Myung-Hwan Kim; Do Hyun Park
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

3.  A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid.

Authors:  J C Delgado; D Turbay; E J Yunis; J J Yunis; E D Morton; K Bhol; R Norman; C A Alper; R A Good; R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 4.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.

Authors:  Diogo Fabris Rabelo; Tegan Nguyen; Brooke Ann Caufield; Abdul Razzaque Ahmed
Journal:  J Dermatol Case Rep       Date:  2014-03-31

Review 6.  [Mucous membrane pemphigoid].

Authors:  M M Holtsche; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 7.  Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment.

Authors:  Panagiotis Georgoudis; Francesco Sabatino; Nora Szentmary; Sotiria Palioura; Eszter Fodor; Samer Hamada; Hendrik P N Scholl; Zisis Gatzioufas
Journal:  Ophthalmol Ther       Date:  2019-01-29

Review 8.  Role of immune cells in the ocular manifestations of pemphigoid diseases.

Authors:  Tanima Bose
Journal:  Ther Adv Ophthalmol       Date:  2019-08-08

9.  Desquamative gingivitis - A clinical sign in mucous membrane pemphigoid: Report of a case and review of literature.

Authors:  Shamimul Hasan
Journal:  J Pharm Bioallied Sci       Date:  2014-04

10.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.